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Zwitterionic molecules are used as an alternative to PEGylation to reduce protein adsorption 
on nanocarriers. Nonetheless, little is known about the effect of zwitterionic modifications 
on the mechanisms cells use for nanocarrier uptake. In this study, the uptake mechanism 
of liposomes containing zwitterionic or negatively charged lipids was characterized using 
pharmacological inhibitors and RNA interference on HeLa cells to block endocytosis. As 
expected, introducing zwitterionic lipids reduced protein adsorption in serum, as well as 
uptake efficiency. Blocking clathrin-mediated endocytosis strongly decreased the uptake 
of the negatively charged liposomes, but not the zwitterionic ones. Additionally, inhibition 
of macropinocytosis reduced uptake of both liposomes, but blocking actin polymerization 
had effects only on the negatively charged ones. Overall, the results clearly indicated 
that the two liposomes were internalized by HeLa cells using different pathways. Thus, 
introducing zwitterionic lipids affects not only protein adsorption and uptake efficiency, 
but also the mechanisms of liposome uptake by cells.
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Introduction
Nanomedicine holds great potential for improving the ways drugs are delivered to their 
targets. Nanocarriers can be used to direct drugs to the diseased tissue, and promote their 
internalization into the targeted cells.1–3 Although the successes of this technology have 
confirmed nanomedicine potential, drug targeting still constitutes a major challenge in 
nanomedicine and more work is required to further improve current outcomes.3–6
One of the challenges in targeting nanomedicines is the adsorption of proteins and 
other biomolecules on their surface, forming a corona once they are applied in biological 
environments.7,8 Protein adsorption and corona formation are usually associated with 
recognition by the immune system and clearance of nanocarriers from the systemic 
circulation.9–12 Corona formation can also affect the targeting ability of nanomedicines by 
masking targeting moieties on the nanocarrier.13,14 At the same time, corona proteins can 
interact with specific cell receptors and facilitate or hamper nanocarrier uptake by cells.15–17 
The composition of the corona depends on the biological environment and the physico-
chemical properties of the nanocarrier, thus changing nanocarrier design can affect both 
the corona composition and – as a consequence of this – nanocarrier interactions with 
cells.12,18–20 
Overall, in order to reduce protein binding, different strategies have been developed. 
The most common is the addition of polymers such as polyethylene glycol on the surface 
of nanocarriers in order to obtain so-called “stealth” surfaces.21–23 Interestingly, recent 
reports have suggested that the stealth character of these nanocarriers is not due to the 
reduction of protein binding, but by the presence of specific corona proteins adsorbing on 
PEGylated surfaces.17 In addition, different strategies are emerging to mask the surface of 
nanocarriers with “markers of self ” to avoid clearance. These include modification with 
self-peptides such as CD47, and other biomimetic approaches where cell membranes from 
red blood cells or leukocytes are used to camouflage nanocarriers.11,24–26
Another common strategy to reduce protein binding is the use of zwitterionic modifications. 
Zwitterionic molecules contain both positive and negative charges, but have a net neutral 
charge. The introduction of zwitterionic groups on nanocarriers, similar to PEGylation, 
leads to reduction of protein binding and increased plasma residence time.27–29 In line with 
these results, we have recently shown that by adding increasing amounts of zwitterionic 
lipids, liposomes with reduced corona binding and lower uptake efficiency by cells could 
be obtained.30 However, not much is known about the impact of zwitterionic modifications 
on the mechanisms cells use to internalize nanocarriers in comparison to charged ones. 
The uptake mechanism can affect nanocarrier uptake efficiency, thus the amount of drug 




The hydrodynamic diameter and zeta potential of the liposomes were measured in 
water, PBS, and Minimum Essential Medium (MEM) (Gibco, Grand Island, New York, 
United States) supplemented with 4 mg/mL human serum (human serum pooled from 
multiple donors from TCS Biosciences (Buckingham, United Kingdom)) (hsMEM) using 
Malvern ZetaSizer Nano ZS (Malvern Instruments, Malvern, United Kingdom). Dynamic 
and electrophoretic light scattering measurements were performed using 40-µL 
cuvettes (Malvern, ZEN0040) and disposable folded capillary cells (Malvern, DTS1070), 
respectively. Per sample, three measurements of each 10 runs were carried out at 25 oC.
Cell culture
Human cervical cancer HeLa cells (CCL-2; ATCC, Manassas, Virginia, United States) 
were cultured in complete culture medium (cMEM) consisting of MEM supplemented 
with 10% foetal bovine serum (FBS) (Gibco). The cells were grown in a T75 flask at 
37 oC and 5% CO2 and split when confluent. Cells were tested monthly to exclude 
mycoplasma contamination and used for experiments till maximum 20 passages 
after defrosting. 
Isolation of corona-coated liposomes and protein corona 
characterization
Corona-coated liposomes were isolated by size exclusion chromatography (SEC) and 
characterized as described in details in the Supplementary information. 
Uptake studies and exposure to chemical inhibitors
Different chemical inhibitors were used to block specific components of endocytosis, 
using previously optimized conditions to ensure drug efficacy and exclude toxicity.46 
HeLa cells were seeded 50,000 cells per well of a 24-well plate. Then, 24 h after 
seeding, cells were pre-treated with cMEM containing one of the inhibitors as 
follows: sodium azide (5 mg/mL) (Merck, Kenilworth, New Jersey, United States) for 
30 min, nocodazole (5 µM) (BioVision Inc., San Francisco, California, United States) 
for 20 min, or chlorpromazine (10 µg/mL) (Sigma Aldrich, St. Louis, Missouri, 
United States), 5-(N-ethyl-N-isopropyl)amiloride (EIPA; 75 µM) (Sigma Aldrich), 
cytochalasin D (5 µg/mL) (Invitrogen, Carlsbad, California, United States), or 
methyl-β-cyclodextrin (MBCD, 2.5 mg/mL) (Sigma Aldrich) for 10 min. Then, cells 
were washed with serum-free medium and incubated with 50 µg/mL liposomes in 
MEM supplemented with 4 mg/mL human serum in standard conditions or in the 
presence of each of the inhibitors. In the case of MBCD, in order to avoid exposure 
to liposomes in the presence of free proteins which can limit drug efficacy,46 HeLa 
cells were exposed to 50 µg/mL corona-coated liposomes in serum-free MEM. For 
delivered intracellularly, as well as the intracellular processing and final fate of 
nanocarriers. All of these factors ultimately contribute to the therapeutic efficacy. 
Thus, in this work phosphatidylglycerol and phosphatidylcholine, both combined 
with cholesterol, were used to prepare – respectively – negatively charged and 
zwitterionic liposomes. Liposomes are very common nanocarriers, usually made 
with neutral and negatively charged lipids for drug delivery, while positively charged 
liposomes are widely applied as non-viral gene delivery systems to bind negatively 
charged nucleic acids.31–35 Even though several liposomal formulations have reached 
the market, not much is known about the effect of charge on the mechanism of 
liposome uptake by cells. Most studies have investigated the uptake mechanism of 
positively charged liposomes for nucleic acid delivery.36,37 Only a few have directly 
compared the mechanisms involved in the internalization of zwitterionic and 
negatively charged liposomes by cells.38–40 To this aim, here we have used a panel of 
common pharmacological inhibitors and RNA interference to block key components 
of different endocytic pathways on HeLa cells,37,41–45 and compared their effect on 
the uptake of negatively charged and zwitterionic liposomes. This allowed us to 




Lipids were purchased from Avanti Polar Lipids (Alabaster, Alabama, United States). 
The zwitterionic lipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or the anionic 
lipid 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (DOPG) were dissolved in 
chloroform and mixed with cholesterol in a 2:1 molar ratio. Additional experiments 
were performed with pure DOPC or DOPG liposomes without cholesterol. The solvent 
was evaporated using nitrogen followed by overnight incubation under vacuum. 
The lipid films were resuspended in 25 mM sulforhodamine B (SRB) dissolved in 
phosphate buffered saline (PBS) at room temperature to a final lipid concentration 
of 10 mg/mL. The suspension was freeze-thawed eight times followed by twenty-
one extrusions through a 0.1 µm polycarbonate membrane with the Avanti Mini-
Extruder (Avanti Polar Lipids). The excess free SRB was removed using Zeba Spin 
Desalting Columns, 7 K molecular weight cut-off (MWCO) (Thermo Fisher Scientific, 
Waltham, Massachusetts, United States). The liposomes were stored at 4 oC and used 
for maximum one month.




To visualize liposome uptake, 1.5 × 105 cells were seeded in 35 mm dishes with a 170 µm 
thick glass bottom. Twenty four hours after seeding, cells were washed with serum-
free medium and incubated with 50 µg/mL liposomes in hsMEM for 3 h, followed by 
lysosome staining with 100 nM LysoTracker Deep Red (Thermo Fisher Scientific) for 
30 min and nuclei staining with 1 µg/mL Hoechst lu33342 Solution in cMEM (Thermo 
Fisher Scientific) for 5 min. Cells were imaged using a DeltaVision Elite microscope 
(GE Healthcare Life Sciences, Marlborough, Massachusetts, United States) with 
a DAPI filter for Hoechst excitation, TRITC filter for liposomes, and CY5 filter for 
LysoTracker. Movies were recorded by acquiring one image every 10 sec for up to 3 
min for cells exposed to DOPC liposomes (Supplementary Video S1) or 2 min for cells 
exposed to DOPG liposomes (Supplementary Video S2). Deconvolution was applied 
using softWoRx 6 acquisition and integrated deconvolution software (GE Healthcare 
Life Science). Images were further processed using ImageJ software (http://www.fiji.
sc), and brightness and contrast were adjusted using the same setting for all samples 
in the series. In order to make the internalized DOPC liposomes visible, an image of 
the DOPC liposome channel with increased brightness is included for comparison.    
Results
Liposome characterization
Liposomes of zwitterionic DOPC or negatively charged DOPG and cholesterol in 
a 2:1 molar ratio were prepared and labelled by incorporating sulforhodamine B 
in the hydrophilic core. In order to compare their mechanisms of uptake, human 
cervical cancer epithelial HeLa cells were selected as a common cell model for similar 
studies.38,41,45,47 Given the strong impact of corona formation on nanoparticle-cell 
interactions and recognition by cell receptors,15,16,45,48 the liposomes were dispersed 
in a medium supplemented with 4 mg/mL human serum (hsMEM), as opposed to 
standard foetal bovine serum, in order to allow a human serum corona formation for 
testing on human cells. Prior to cell studies, the zeta potential and hydrodynamic size 
of the liposomes in relevant media were determined by electrophoretic and dynamic 
light scattering (DLS) (Figure 1A-B). DLS showed that liposomes of comparable size 
distribution were obtained, with a diameter of approximately 100 nm in PBS and a 
low polydispersity index and they remained stable once dispersed in medium with 
human serum (Supplementary Figure S1).  The zeta potential of DOPG liposomes in 
DPBS was strongly negative (-40 ± 3 mV), and was attenuated in hsMEM (-8 ± -1 mV) 
upon corona formation. The zwitterionic DOPC liposomes in DPBS had neutral zeta 
potential (-1 ± 1 mV), which in hsMEM converged to values similar to DOPG liposomes 
this purpose, 0.5 mg/mL liposomes were dispersed in 40 mg/mL human serum for 
1 h at 37 ºC. The mixed solution was then loaded on a SEC column and the eluted 
fractions containing liposomes were collected as described above and added to cells 
to a final lipid concentration of 50 µg/mL. As a control for chlorpromazine, EIPA, and 
MBCD efficacy, the uptake of –respectively - 1 µg/mL human low-density lipoprotein 
labelled with BODIPY (LDL-BODIPY) (Invitrogen) in serum-free MEM, 250 µg/mL 10 
kDa Tetramethylrhodamine dextran (Invitrogen) in cMEM, and 0.1 µM BODIPY FL 
labelled LacCer (Invitrogen) in serum-free MEM was measured in standard conditions 
or in the presence of the drug. To confirm cytochalasin D and nocodazole efficacy, 
immunostaining was used as described in details in the Supplementary information.
RNA interference
In order to silence the expression of dynamin-1 and dynamin-2, 13,000 HeLa cells 
were plated per well of a 24-well plate. Twenty four hours after seeding, cells were 
washed with serum-free MEM for 15 min. Oligofectamine-siRNA complexes were 
formed by mixing 1 µL of Oligofectamine transfection reagent (Life Technologies, 
Carlsbad, California, United States) with 10 pmol of siRNA (Thermo Fisher Scientific) 
against either dynamin-1 (Silencer Select S144) or dynamin-2 (Silencer Select S4213), 
or scrambled siRNA (Silencer Select negative control no. 1) in 49 µL of OptiMEM. 
After 20 min incubation in room temperature, the complexes were diluted in serum-
free MEM to a total volume of 250 µL, and were added to the cells. After 4 h, MEM 
supplemented with FBS was added to a final concentration of 10% FBS. Three 
days after transfection, cells were exposed to either liposomes (50 µg/mL in MEM 
supplemented with 4 mg/mL human serum) or – as a control – Alexa Fluor 647 labelled 
human transferrin (5 µg/mL in serum-free MEM) (Invitrogen) and their uptake was 
measured using flow cytometry.
Flow cytometry analysis
After exposure to the liposome or the different controls, cells were washed once with 
cMEM and twice with PBS to reduce the presence of liposomes or fluorescent probes 
on the outer cell membrane. Cells were detached by exposure to trypsin/EDTA (0.05% 
in PBS) for 5 min at 37 oC and collected after centrifugation at 300 � g for 5 min. Cells 
were then resuspended in 100 µL PBS for flow cytometry analysis using CytoFLEX S 
(Beckman Coulter, Indianapolis, Indiana, USA). Gates were set in the forward and 
side scattering plots to exclude cell debris and doublets and at least 10,000 single cells 
were acquired, unless indicated otherwise. Data were analysed using FlowJo software 
(Becton, Dickinson & Company, Ashland, Tennessee, United States), and the average 
and standard deviation of the median cell fluorescence intensity over 3 replicates 
were calculated (unless stated differently).
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in the same media. We previously showed that, consistent with their different charge, 
the DOPG liposomes adsorbed more proteins than the DOPC liposomes, and the 
resulting corona composition differed strongly, as also confirmed here by SDS-PAGE 
of the corona proteins in Figure 1C.30 
Uptake kinetics and uptake mechanisms
As a next step, liposome uptake kinetics were determined by flow cytometry. As we 
previously observed,30 the uptake kinetics of the two formulations differed strongly. 
Even though multiple liposome batches with variable fluorescence were used, in all 
cases DOPG liposomes showed much higher uptake in the first hours, in comparison 
to the zwitterionic DOPC (Figure 1D). This is in agreement with previous studies with 
similar formulations.29,49,50  Higher uptake for the DOPG liposomes was observed also 
when liposomes were added to cells in artificial serum-free conditions, thus when the 
different charge was not masked by the adsorbed proteins (Supplementary Figure S2). 
To determine whether the liposomes entered through an active process or passive 
fusion with the cell membrane, sodium azide was used to deplete cell energy (Figure 
1E). The very strong reduction of uptake in energy-depleted cells (on average 75 and 
90% for DOPC and DOPG liposomes, respectively) indicated that they both entered 
cells through an energy-dependent mechanism. Live cell imaging confirmed that 
both liposomes entered the cells and accumulated in the lysosomes (Figure 1F, 
Supplementary Figure S3, and corresponding Supplementary videos S1 and S2).
Similar experiments were performed for comparable formulations without cholesterol 
in the liposome membrane (Supplementary Figure S4): also in this case uptake was 
higher for the (pure) DOPG liposomes and energy depletion reduced uptake, though 
the effect was smaller than for liposomes containing cholesterol (40-50% uptake 
reduction). This suggests that also without cholesterol in the liposome bilayer uptake 
was at least in part energy-dependent.
As a next step, to characterize the mechanisms of uptake, several key components 
of endocytic pathways were blocked using a panel of common chemical inhibitors 
or RNA interference.42–44,51 We previously optimized in detail the conditions to use 
these compounds on HeLa cells in order to exclude toxicity and demonstrate drug 
efficacy with appropriate controls.46 In line with these studies, internalization 
of fluorescently labelled molecules or fluorescent staining were included in each 
individual experiment as a control (Figure 2, all left panels). An example of liposome 
uptake kinetics in standard conditions and in the presence of each of the different 
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overview of inhibition efficacy in replicate experiments is included in Figure 3, 
together with additional studies after cholesterol depletion from the cell membrane.
One of the major pathways of uptake is clathrin-mediated endocytosis (CME). Here, 
CME was inhibited using chlorpromazine.52 The strong reduction of low-density 
lipoprotein (LDL) uptake confirmed chlorpromazine efficacy (Figures 2A and 3A). 
Interestingly, chlorpromazine reduced the uptake of DOPG liposomes strongly (on 
average 55% over time), but had no effect on DOPC uptake. 
To investigate the role of two major cytoskeleton components, the polymerization 
of F-actin and microtubules was blocked using cytochalasin D and nocodazole, 
respectively.53,54 As shown in Figure 2B and C, fluorescent microscopy confirmed the 
disruption of actin filaments and microtubuli after exposure to these compounds. 
Cytochalasin D reduced DOPG uptake by 80% after 3 h, but had only minor effect 
on DOPC (roughly 30% uptake reduction, as shown in Figures 2B and 3B). Similarly, 
disruption of microtubules with nocodazole reduced DOPG uptake up to a maximum 
of 50%, while DOPC uptake was less affected (maximum 30% reduction, Figures 2C 
and 3C). 
We then tested the involvement of macropinocytosis, an actin-dependent process cells 
use to internalize extracellular fluids and solutes (Figures 2D and 3D). This pathway 
can be inhibited by amilorides like ethylisopropylamiloride (EIPA) which blocks Na+/
H+ exchange.55 As a control, the uptake of fluorescently labelled dextran was reduced 
by approximately 60% upon exposure to EIPA. EIPA treatment had clear effects 
also on the uptake of both liposomes. However, in the case of DOPC liposomes the 
effect was stronger at increasing exposure time (from 30% after 1 h, up to 60% uptake 
reduction after 7 h), while for the DOPG liposomes uptake was reduced by 75% already 
after 1 h (Figures 2D and 3D). This suggested that this pathway may be involved in 
the uptake of both liposomes, but to a different extent. Nonetheless, caution should 
be taken in interpreting these results, because amilorides block macropinocytosis by 
lowering the submembranous pH, thereby preventing Rac1 and Cdc42 activation,55 
which are essential for this mechanism. However, these proteins are involved also in 
other clathrin-independent endocytic mechanisms.56 
Another key component for multiple endocytic pathways, including CME, is the 
GTPase dynamin, involved in the scission of the invaginations from the plasma 
membrane.56 Dynasore is a commonly used inhibitor of dynamin. However, we have 
previously shown that its activity is lost in medium supplemented with serum.46 
Thus, RNA interference was used and HeLa cells were transfected with siRNA against 
Figure 2. Characterization of the uptake mechanisms of negatively charged and zwitterionic liposomes in HeLa 
cells. HeLa cells were exposed to DOPC and DOPG liposomes (50 µg/mL) in MEM medium supplemented with 4 mg/mL 
human serum (hsMEM) in standard conditions (untreated) or in the presence of (A) chlorpromazine (10 µg/mL, CP), (B) 
cytochalasin D (5 µg/mL, cytoD), (C) nocodazole (5 µM), (D) EIPA (75 µM) or (E) after RNA interference against dynamin-1 
(DNM-1 siRNA) (with cells transfected with neg siRNA for scrambled RNA used as a control, see Methods for details). 
In the left panels, the uptake of (A) 1 µg/mL  BODIPY-labelled LDL in sfMEM, (D) 250 µg/mL tetramethylrhodamine-
labelled 10 kDa dextran in standard cMEM, or (E) 5 µg/mL Alexa-Fluor 647-labelled transferrin in sfMEM were used 
as controls to confirm the effects of the different treatments; while staining of (B) actin and (C) α-tubulin was used to 
confirm inhibition by cytochalasin D and nocodazole, respectively. The results are the mean and standard deviation over 3 
samples (2 samples when marked with *) of the median cell fluorescence intensity obtained by flow cytometry in a 
representative experiment.
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DNM1 or DNM2 (Figures 2E, 3E and Supplementary Figure S5). Silencing DNM2 had 
only minor effects on transferrin uptake, which depends on dynamin (Supplementary 
Figure S5). On the contrary, silencing DNM1 reduced transferrin uptake by around 
60%, confirming efficient silencing (Figures 2E). DOPC uptake was not affected by 
silencing of either DNM1 or DNM2 (Figure 2E, 3E and Supplementary Figure S5, 
respectively). Instead, for the DOPG liposomes slightly higher uptake was observed 
after silencing DNM1 (Figure 2E), and no clear effects in cells silenced for DNM2 (only 
30% reduction after 1 h, as shown in Supplementary Figure S5). Overall, the absence 
of effects in cells silenced for DNM1, for which a clear reduction of transferrin uptake 
was confirmed, suggested that this protein is not involved in liposome uptake (Figures 
2E and 3E). Further studies are required to fully elucidate the potential involvement 
of DNM2.
Another key component for several endocytic pathways is the cholesterol in the cell 
membrane (Figure 3F).51 Cholesterol-dependency is often studied using methyl-
β-cyclodextrin (MBCD), which sequesters cholesterol from the cell membrane.51 
However, as for dynasore, we previously showed that this compound loses its 
efficacy in the presence of serum.46 Thus, in order to gain some indications on the 
potential contribution of cholesterol in the cell membrane to the entry of DOPC and 
DOPG liposomes into cells, corona-coated liposomes were isolated by size exclusion 
chromatography, as we previously described.30 Then, the corona-coated liposomes 
were added to cells in serum-free medium in standard conditions or in the presence 
of MBCD (Figure 3F). The uptake of LacCer, a sphingolipid known to enter cells via 
cholesterol-dependent mechanisms,42 was reduced by 65% in cells exposed to MBCD, 
confirming efficient cholesterol depletion. Similarly, cholesterol depletion had strong 
effects on the uptake of both liposomes (roughly 40% uptake reduction for DOPC and 
60% for DOPG, Figure 3F), suggesting that cholesterol in the cell membrane plays a 
role in the entry of both liposomes into HeLa cells.
Similar studies were also performed for comparison in other cell lines, namely human 
lung cancer A549 epithelial cells and liver endothelial TRP3 cells (Supplementary 
Figure S6 and S7, respectively).57 Also in these cells, DOPG uptake was higher than for 
DOPC liposomes. In A549 cells, experiments with sodium azide confirmed that uptake 
was energy-dependent but none of the inhibitors tested had effects on the uptake of 
the two liposomes (see details in Supplementary Figure S6). In TRP3 cells, instead, 
similar to what observed in HeLa (Figures 2 and 3), chlorpromazine and cytochalasin 
D strongly reduced the uptake of the negatively charged DOPG liposomes, but had 
only minor or no effect on the uptake of the zwitterionic DOPC. Thus, also in TRP3 
cells the two liposomes were internalized via different mechanisms.
Figure 3. Overview of liposome uptake inhibition in HeLa cells after treatment with the panel of chemical 
inhibitors or RNA interference. HeLa cells were exposed to DOPC and DOPG liposomes (50 µg/mL) in MEM 
medium supplemented with 4 mg/mL human serum (hsMEM) in standard conditions or in the presence of (A) 
chlorpromazine (10 µg/mL), (B) cytochalasin D (5 µg/mL), (C) nocodazole (5 µM), (D) EIPA (75 µM) or (E) after 
RNA interference against dynamin-1. Additionally, (F) uptake of corona-coated liposomes in sfMEM (50µg/mL 
lipid, isolated as described in the Methods) and, as a control, 0.1 µM BODIPY-FL labelled LacCer in sfMEM in the 
presence of methyl-β-cyclodextrin (MBCD, 2.5 mg/mL) was also measured. The symbols are the results obtained 
in individual experiments (3 to 4 independent experiments) and show the median cell fluorescence intensity 
averaged over 3 samples (2 samples when marked with *), normalized by the results in untreated control cells. 
The lines are the average over the independent experiments. A black dashed line and a red dashed line are 
included in each panel as a reference, at 100% and 60% uptake, respectively (with 60% uptake shown as an 
indicative threshold for inhibition efficacy). In one case, marked with †, for one of the replicate experiments only 
around 4000 single cells were acquired.
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2:1 used in this study) and also by the use of bovine serum instead of human serum 
for liposome dispersion. It is intriguing to see that small differences in liposome 
formulation or exposure condition may lead to rather different outcomes at cell 
level. When performing similar experiments using other cell types, interestingly in 
A549 cells, none of the inhibitors tested had effects on liposome uptake, even though 
controls confirmed drug efficacy (Supplementary Figure S6). Others methods need 
to be applied to understand how the two liposomes are internalized by these cells 
and eventual differences in the mechanisms used. Instead, in TRP3 cells, similar to 
what observed in HeLa cells, chlorpromazine and cytochalasin D strongly reduce the 
uptake of the negatively charged DOPG but had minor or no effect on the uptake of 
the zwitterionic DOPC liposomes (Supplementary Figure S7). Thus, also in these cells 
different mechanisms were used to internalize the two liposomes.
At a broader level, it is interesting to notice that a relatively small difference in the 
head group of one of the lipids used for the formulation of liposomes, which otherwise 
are highly similar (same size, same cholesterol amount, same dioleoyl chains), can 
have such profound effects not only on the amount and identity of proteins adsorbed 
once in contact with serum, as well as on uptake efficiency,27–30,38,50 but also on the 
subsequent mechanisms of uptake by cells. Liposome charge itself affects uptake 
efficiency, as observed when adding the liposomes to cells in artificial serum-free 
conditions (Supplementary Figure S2), where the different compositions is reflected 
on the very different zeta potential (as shown in Figure 1B for liposomes in DPBS). 
However, cells are unlikely to interact with bare liposomes, since once applied in a 
biological environment, they are quickly modified by corona formation. In line with 
this, the zeta potential of the two formulations converged to very similar values upon 
exposure to serum (also in Figure 1B). Nevertheless, despite the comparable size and 
similar charge acquired upon corona formation, liposome uptake efficiency as well as 
uptake mechanisms differed strongly. This suggests that for the final corona-coated 
liposomes, the original charge of the bare liposomes is less relevant in determining 
the outcomes with cells. Likely, it is the nature and amounts of the proteins adsorbed 
to determine the strong differences observed in the uptake efficiency and uptake 
mechanism used by cells to process apparently similar complexes. In line with 
this hypothesis, Schöttler et al. have previously reported that the adsorption of 
clusterin in the corona formed on PEGylated nanocarriers leads to reduced uptake 
by cells.17 Similar effects may play a role also in the lower uptake observed for 
zwitterionic liposomes and it would be interesting to determine which proteins 
may be responsible for it. Similarly, identifying the receptors involved in the higher 
uptake of the negatively charged DOPG liposomes, as well as potential corona 
proteins recognized by such receptors, could provide useful information to achieve 
Discussion
In this study, the uptake mechanisms of charged and zwitterionic liposomes 
were compared. Positively charged liposomes are often used to complex and carry 
oligonucleotides, however for drug delivery many of the currently approved liposomal 
formulations are negatively charged.58,59 Thus, here we compared the mechanism of 
uptake of negatively charged liposomes made with DOPG and zwitterionic DOPC 
liposomes. Zwitterionic surfaces are known to reduce protein binding and can lead 
to lower uptake by cells, as indeed we also confirmed here (Figure 1).27–30,38,50 However, 
the effect of zwitterionic modifications on the mechanisms cells use to internalize 
liposomes has not been fully characterized. The uptake mechanism can affect uptake 
efficiency, thus the load of drug delivered inside cells, as well as the uptake kinetics, 
intracellular distribution and final fate of nanocarriers inside cells. All of these aspects, 
together, ultimately affect drug efficacy, thus it is important to determine how the 
cell uptake mechanism varies for charged and zwitterionic liposomes. For both 
liposomes, uptake was energy-dependent (Figure 1E), excluding some form of passive 
uptake via direct fusion with the cell membrane. Indeed, the adsorption of the protein 
corona on the liposomes is likely impairing the possibility for a direct fusion between 
the lipids of the liposomes and of the cell membrane. Thus, as summarized in Figure 
3, we have found that blocking a series of key components of the major mechanisms 
of endocytosis, had very different effects on the uptake of negatively charged and 
zwitterionic liposomes. In the case of the DOPG liposomes, internalization was 
reduced by most inhibitors used, which could suggest the involvement of multiple 
pathways. Nevertheless, caution should be taken in interpretation of these results, 
since many of the components investigated (like for instance actin, microtubules, and 
cholesterol) have a role in multiple endocytic mechanisms and it is know that some of 
these chemical compounds may influence multiple pathways at the same time.42,46,51 
For DOPC liposomes, instead, uptake was clearly clathrin-independent (Figure 3A), 
and only cholesterol depletion and treatment with EIPA partially reduced it (Figures 
3F and 3D, respectively). The latter suggested an involvement of macropinocytosis, 
however – in contrast with these results - blocking actin polymerization with 
cytochalasin D did not affect uptake (Figure 3B). Given that actin is an essential 
component in macropinocytosis, one may interpret the observed uptake reduction 
with EIPA as a sign of the involvement of other Rac1 and Cdc42 dependent pathways.56 
In contrast with our results, Un et al. showed reduced uptake of DOPC-cholesterol 
liposomes by HeLa cells after inhibition of CME, and no effects when blocking 
macropinocytosis or after cholesterol depletion.38 The different results may be 
explained by the different DOPC to cholesterol ratio (1:1 molar ratio, as opposed to 
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higher nanocarrier uptake by cells. We have previously shown that recognition by cell 
receptors of different coronas may lead to different uptake mechanisms by cells and 
this in turns can also affect uptake efficiency and kinetics.45 Thus, for efficient drug 
delivery, the details of the receptors and mechanisms involved in nanocarriers uptake 
need to be determined, since they can strongly affect delivery efficiency. 
These results stress once more that the chemical identity of a nanocarrier alone 
does not allow to predict its outcomes on cells. Instead, it is the biological identity 
acquired once nanocarriers are applied in biological environment that modulates 
interactions with cell receptors, and determines consecutively the mechanism of 
uptake by cells and uptake efficiency. This is another example suggesting the need for 
a deeper understanding of the effect of corona formation on the way cells recognize 
and process nano-sized materials.
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Isolation of corona-coated liposomes and protein corona characterization. 
Corona-coated liposomes were isolated by size exclusion chromatography (SEC) 
with a Sepharose CL-4B (GE Healthcare Life Sciences, Marlborough, Massachusetts, 
United States) column (15 × 1.5 cm). We have previously shown that in human serum 
aggregates of sizes comparable to liposomes can be present, which elute together 
with the liposomes, thus contaminating the corona samples.1 To remove similar 
contamination, for the characterization of corona proteins, human serum was first 
depleted from such objects using size exclusion chromatography (SEC), as previously 
described.1 Thus, 75 µg/mL liposomes were incubated with 6 mg/mL particle-depleted 
human serum for 1 h at 37 oC while shaking to allow corona formation. Corona-coated 
liposomes were then isolated by SEC. Fractions of 0.5 mL eluent were collected 
and the absorbance of proteins at 280 nm and SRB at 560 nm were measured with 
a NanoDrop One spectrophotometer (Thermo Fisher Scientific, Wilmington, North 
Carolina, United States). Then, the fractions containing liposomes were pooled 
together and concentrated with a Vivaspin 6 centrifugal concentrator (10K MWCO; 
Sartorius, Yauco, Puerto Rico, United States) at 1600 x g. 
Protein concentration was quantified using the Bio-Rad DC protein assay (Bio-
Rad Laboratories, Hercules, California, United States). A calibration curve was 
constructed using bovine serum albumin (Sigma Aldrich, St. Louis, Missouri 
United States). Lipid concentrations were determined using a method based on the 
Stewart assay. Briefly, samples were mixed with chloroform and a ferrothiocyanate 
reagent (composed of 27.0 mg ferric chloride hexahydrate (Sigma Aldrich, St. Louis, 
Missouri, United States) and 30.4 mg ammonium thiocyanate (Sigma Aldrich, St. 
Louis, Missouri, United States) in 1 mL Milli-Q water) in a 1:50:50 volume ratio and 
vortexed for 1 min. After centrifugation at 300 x g for 10 min, the chloroform layer was 
collected and absorbance at 470 nm was measured in a quartz cuvette with a Unicam 
UV500 Spectrophotometer (Unicam Instruments, Cambridge, United Kingdom). For 
each sample, a standard curve made with samples at known concentrations of the 
same mixture of lipids as in the liposomes was used. 
Then, the isolated corona proteins were separated by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS-PAGE). Corona-coated liposomes corresponding 
to equal amounts of lipids (0.025 µmol lipids, as measured by the lipid assay described 
above) were combined with loading buffer (80 mg/mL SDS, 62 mg/mL DTT, and 40% 
glycerol in 0.25 M Tris-HCl buffer, pH 6.8, containing bromophenol blue). After 5 min 
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conditions or in the presence of the drug. The exposure time for transferrin was 10 
min and for dextran 5 hours.
Cell culture of TRP3 cells. The immortalized human liver endothelial sinusoidal 
cell line, TRP3, was kindly provided by Birke Bartosch and Romain Parent.2 Cells 
were cultured in MCDB 131 medium (Gibco, Grand Island, New York, United States) 
supplemented with 20% FBS (Gibco), 10 mM glutamine (Thermo Fisher Scientific), 
250 µg/ml cAMP (Sigma-Aldrich), 1 µg/ml hydrocortisone (Sigma-Aldrich), and 50 µg/
ml endothelial cell growth supplement (ECGS, Corning). Cells were grown in a T75 
flask pre-coated with 0.1% cold gelatine (Sigma-Aldrich) at 37 °C and 5% CO2 and the 
medium was refreshed every 2–3 days. Cells were tested against mycoplasma monthly 
to exclude mycoplasma contamination.
Exposure of TRP3 cells to chemical inhibitors. Uptake study with chemical inhibitors 
were performed on TRP3 cell barriers. To develop cell barriers, TRP3 cells were 
seeded at 90.000 cells per well in a 24-well plate pre-coated with 0.1% cold gelatine 
(Sigma-Aldrich) and cultured for an additional three days with medium refreshed 
every two days. After this, cells were pre-treated with complete medium containing 
chlorpromazine (10 µg/mL) (Sigma Aldrich, St. Louis, Missouri, United States) or 
cytochalasin D (2.5 µg/mL) (Invitrogen, Carlsbad, California, United States) for 10 
min. The cells were washed with serum-free medium and incubated with 50 µg/
mL liposomes in medium supplemented with 4 mg/mL human serum in standard 
conditions or in the presence of each of the inhibitors. After 5 hours liposome 
exposure, cells were collected for flow cytometry measurement. As a control for 
chlorpromazine efficacy, the uptake of Alexa Fluor 647-labelled transferrin (5 µg/mL 
in sfMEM) (Invitrogen) after 10 min exposure was measured in standard conditions 
or in the presence of 10 µg/mL chlorpromazine.
at 95 oC, samples were loaded on a 10% polyacrylamide gel and run for 90 min at 100 
V. Proteins were stained with Coomassie blue. Gels were scanned with a ChemiDoc 
XRS (Bio-Rad Laboratories, Hercules, California, United States).
Fluorescence imaging. To confirm cytochalasin D and nocodazole efficacy, cells 
were seeded in wells containing glass coverslips (50,000 cells per well of a 24-well 
plate). After incubation with the chemical inhibitors, cells were washed once with 
cMEM and twice with PBS. Cells were fixed with 4% formaldehyde for 20 min at room 
temperature and permeabilized with 1 mg/mL saponin for 5 min. After three washes 
with PBS, actin filament were stained with phalloidin-TRITC (1:1000) (Sigma Aldrich) 
for 1 h at room temperature in the dark. Microtubuli were stained with anti-α-tubulin 
antibody (Merck) for 1 h, followed by a 1 h incubation with an Alexa-Fluor 488 labelled 
secondary anti-mouse antibody (Thermo Fisher Scientific). Nuclei were labelled with 
0.2 µg/mL 4’,6-diamidino-2-phenylindole (DAPI) for 5 min. Cells were washed with 
PBS after each staining. Coverslips were mounted on glass slides using MOWIOL 
(Merck). Images were taken with a Leica DM4000B fluorescence microscope (Leica 
Microsystems, Wetzlar, Germany).
A549 cell culture. Adenocarcinomic human alveolar epithelial A549 cells (CCL-185; 
ATCC, Manassas, Virginia, United States) were cultured in complete culture medium 
(cMEM) consisting of MEM supplemented with 10% foetal bovine serum (FBS) (Gibco). 
The cells were grown in a T75 flask at 37 oC and 5% CO2 and split when confluent and 
tested once a month to exclude mycoplasma contamination. Cells were used for 
experiments till maximum 20 passages after defrosting. 
Exposure of A549 cells to chemical inhibitors. A549 cells were seeded 50,000 cells 
per well of a 24-well plate. Then, 24 h after seeding, cells were pre-treated with 
cMEM containing one of the inhibitors as follows: sodium azide (5 mg/ml) (Merk, 
Kenilworth, New Jersey, United States) for 30 min, chlorpromazine (8 µg/mL) (Sigma 
Aldrich, St. Louis, Missouri, United States), cytochalasin D (2.5 µg/mL) (Invitrogen, 
Carlsbad, California, United States), EIPA (75 mM) (Sigma Aldrich) for 10 min, or 
nocodazole (5 mM) (BioVision Inc., San Francisco, California, United States) for 20 
min. The cells were washed with serum-free medium and incubated with 50 µg/
mL liposomes in MEM supplemented with 4 mg/mL human serum in standard 
conditions or in the presence of each of the inhibitors. After 5-hour exposure (except 
3 hours for sodium azide), cells were collected for flow cytometry measurement. As a 
control for chlorpromazine and EIPA efficacy, the uptake of -respectively- Alexa Fluor 
647-labelled transferrin (5 µg/mL in sfMEM) (Invitrogen) and tetramethylrhodamine-
labelled 10 kDa dextran (250 µg/ml in cMEM) (Invitrogen) was measured in standard 
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Supplementary Figure S1. Stability of liposomes in different media over time. (A) DOPC or (B) DOPG liposomes 
were dispersed at a concentration of 50 µg/mL in water, PBS, or MEM medium supplemented with 4 mg/mL 
human serum (hsMEM) and incubated in 5% CO2 humidified atmosphere at 37 °C for increasing times in order to 
monitor liposome stability in the conditions applied for exposure to cells. The results are the size distributions 
obtained after CONTIN analysis of dynamic light scattering data. Both DOPC and DOPG liposomes were stable in 
water, PBS and hsMEM and stability was maintained up to 24 h in the conditions used for experiments with cells.
Supplementary Figure S2. Uptake of liposomes in serum-free medium. HeLa cells were exposed to 50 µg/mL 
DOPG or DOPC liposomes in serum-free MEM, thus without a serum corona on their surface. The results are the 
mean and standard deviation (too small to be visible) over 2 replicates of the median cell fluorescence intensity 
measured by flow cytometry and show that in (artificial) serum-free conditions, when the different charge is 
not masked by the protein corona (as suggested by the strongly different zeta potential in DPBS, see Figure 1B), 
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Supplementary Figure S4. Uptake of pure DOPC and DOPG liposomes without cholesterol in the lipid bilayer. 
Uptake kinetics by HeLa cells of 50 µg/mL pure DOPC and DOPG liposomes (without cholesterol) in hsMEM in 
standard conditions or in the presence of 5 mg/mL NaN3 to deplete cell energy. The results are the mean and 
standard deviation (often too small to be visible) over two replicates of the median cell fluorescence obtained 
by flow cytometry. Even in the absence of cholesterol in the liposome bilayer, uptake was observed and was 
much higher for DOPG liposomes. Energy depletion by exposure to NaN3 reduced uptake of around 40-50%, 
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Supplementary Figure S7. Liposome uptake in TRP3 cells after treatment with chemical inhibitors. (A) 
TRP3 cells were exposed for 5 hours to 50 µg/mL DOPC or DOPG liposomes in medium containing 4 mg/mL 
human serum protein (hsMEM) in the presence of chlorpromazine (10 µg/mL) or cytochalasin D (2.5 µg/mL). 
As control for chlorpromazine, uptake of 5 µg/mL Alexa Fluor 647-labelled transferrin in sfMEM was measured 
(10 min exposure). The results are the mean and standard deviation over three replicates (two replicates for 
the transferrin control) of the median cell fluorescence intensity obtained by flow cytometry. (B) The same 
results are shown after normalization by the results in untreated cells. A black dashed line and a red dashed 
line are included as a reference, at 100% and 60% uptake, respectively (with 60% uptake shown as an indicative 
threshold for inhibition efficacy). The results showed that also in TRP3 cells, the uptake of the negatively charged 
DOPG liposomes was much higher than for the zwitterionic DOPC. Similar to what was observed in HeLa cells 
(Figures 2 and 3), chlorpromazine and cytochalasin D strongly reduced DOPG uptake, but had no or only minor 
effects on the uptake of DOPC. This confirmed that also in these cells, the two liposomes were internalized via 
different mechanisms.
Supplementary Figure S6. Liposome uptake in A549 cells. (A) A549 cells were exposed to 50 µg/mL DOPC or 
DOPG liposomes in medium containing 4 mg/mL human serum protein (hsMEM). The results are the mean and 
standard deviation over 3 replicates of the median cell fluorescence intensity measured by flow cytometry. Due 
to the high difference in uptake of DOPC and DOPG, the y-axis is broken to be able show the results in one graph. 
Also, in A549 cells the uptake of DOPG liposomes was much higher than for DOPC liposomes. (B) Uptake of 50 
µg/mL DOPC and DOPG in hsMEM by A549 cells was measured after 3 hours exposure in standard conditions or 
in the presence of 5 mg/mL NaN3 to deplete cell energy. The results confirmed that also in these cells, uptake was 
energy-dependent. (C) A549 cells were exposed for 5 hours to DOPC and DOPG liposomes (50 µg/mL) in hsMEM 
in standard conditions or in the presence of chlorpromazine (8 µg/mL), cytochalasin D (2.5 µg/mL), nocodazole 
(5 µM), or EIPA (75 µM). As control for chlorpromazine and EIPA treatment uptake of 5 µg/mL Alexa Fluor 
647-labelled transferrin in sfMEM (10 min exposure) or 250 µg/ml tetramethylrhodamine labelled 10 kDa dextran 
in hsMEM (5-hour exposure) was measured. The results in panel B and C are the mean and standard deviation 
over three replicates (two replicates for the controls) of the median cell fluorescence intensity obtained by flow 
cytometry, normalized by the results in untreated cells. A black dashed line and a red dashed line are included 
as a reference, at 100% and 60% uptake, respectively (with 60% uptake shown as an indicative threshold for 
inhibition efficacy). While the controls confirmed drug efficacy, none of the inhibitors tested reduced the uptake 
of the two liposomes. Other methods are required to characterize their mechanisms of uptake in these cells.
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Supplementary Video S1 and S2. Live HeLa cells exposed to 50 µg/mL DOPC (Supplementary Video S1) and DOPG 
(Supplementary Video S2) liposomes (red) in hsMEM for 3 h. Blue: Hoechst stained nuclei. Green: LysoTracker to 
stain acidic compartments (scale-bar, 10 µm). Movies were recorded by acquiring one image every 10 sec for up to 3 
min for cells exposed to DOPC liposomes (Supplementary Video S1) or 2 min for cells exposed to DOPG liposomes 
(Supplementary Video S2). Live cell imaging confirmed that both liposomes entered cells and were trafficked to 
the lysosomes. To confirm DOPC uptake and intracellular location, in video S1 the brightness in the DOPC channel 
was increased. Images taken from these videos are included in Figure 1F and Supplementary Figure S2.
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